XIST and breast cancer: Moreover, the expression levels of XIST and TSIX are related to PD-L1 in the tissues and body fluids of BC patients with diverse molecular subtypes, indicating the role of the two lncRNAs as predictive biomarkers for immunotherapy in BC patients 137.